Vemurafenib Recruiting Phase 2 Trials for Non-Small-Cell Lung Carcinoma (NSCLC) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02314481Deciphering Antitumour Response and Resistance With INtratumour Heterogeneity